FINANCIAL
STATEMENTS FOR THE PERIOD ENDED
31 MARCH 2023
Chemical and Allied Products Plc
Unaudited Financial Statements
For the Period Ended 31 March 2023
Contents | |
Financial Highlights | 3 |
Statement of profit or loss and other comprehensive income | 4 |
Statement of financial position | 5 |
Statement of cash flows | 6 |
Statement of change in Equity | 7 |
Notes to the Financial Statements | 8-41 |
2
Chemical and Allied Products Plc
Unaudited Financial Statements
For the Period Ended 31 March 2023
Financial highlights | 3 Months to | 3 Months to | |
% | |||
Mar 2023 | Mar 2022 | ||
₦'000 | ₦'000 | change | |
Revenue | 3,971,244 | 4,655,782 | (15) |
Operating profit | 390,894 | 760,085 | (49) |
Finance income | 208,099 | 21,651 | 861 |
Profit before taxation | 576,496 | 781,326 | (26) |
Taxation | (187,361) | (250,024) | (25) |
Profit for the year | 389,135 | 531,301 | (27) |
Total equity and liabilities | 15,112,129 | 12,331,544 | 23 |
Additions to property, plant & equipment (PPE) | 126,082 | 91,566 | 38 |
Depreciation on PPE | 107,869 | 73,720 | 46 |
Cash and cash equivalents | 3,746,530 | 2,112,971 | 77 |
Earnings per share (kobo) - Basic and diluted | 48 | 67 | (29) |
Net asset per share (kobo) - Basic | 887 | 627 | 41 |
3
Chemical and Allied Products Plc
Unaudited Statement of Profit or Loss and Other Comprehensive Income For the Period Ended 31 March 2023
Revenue
Cost of sales
Gross profit
Selling and Marketing expenses Administrative expenses Other income
Operating profit
Finance income
Finance cost
Net Finance income
Profit before taxation
Income tax expense
Profit for the year
Other comprehensive income for the year net of tax
Total comprehensive income for the year
Earnings per share for profit attributable to the equity holders of the company:
Notes
5
7i
7iii
7ii
6
9
10
11
3 Months to | 3 Months to |
Mar 2023 | Mar 2022 |
₦'000 | ₦'000 |
3,971,244 | 4,655,782 |
(2,612,882) | (2,848,069) |
1,358,362 | 1,807,713 |
(340,115) | (450,482) |
(736,882) | (637,810) |
109,530 | 40,664 |
390,894 | 760,085 |
208,099 | 21,651 |
(22,496) | (411) |
185,602 | 21,240 |
576,496 | 781,326 |
(187,361) | (250,024) |
389,135 | 531,301 |
389,135531,301
Basic and diluted EPS (kobo)
13
4867
The financial statements have been approved and authorised for issue by the board of Directors on 19th April, 2023
The accompanying notes to the financial statements form part of these financial statements.
4
Chemical and Allied Products Plc Unaudited Statement of Financial Position For the Period Ended 31 March 2023
Assets
Non-current assets Property, plant and equipment Right of use asset Intangible assets
Finance lease receivable
Current assets
Inventories
Trade and other receivables Finance lease receivable Prepayments
Cash and cash equivalents
Assets held for sale
Total assets
Liabilities Non-current liabilities Lease Liability
Deferred taxation liabilities
Current liabilities
Trade and other payables Lease liability
Current income tax liabilities Import finance facility Dividend payable
Total liabilities
Ordinary share capital Share premium
Other Reserves from business combination
Retained Earnings
Equity attributable to equity holders of the Company Total equity
Total equity and liabilities
Notes
14
16
15
18b
17
18a
18b
19
20
24
23
21
24
11
26
12
21
21
2023 | 2022 |
₦'000 | ₦'000 |
1,730,311 | 1,723,492 |
9,706 | 11,206 |
376,297 | 394,821 |
10,372 | 10,372 |
2,126,686 | 2,139,891 |
6,153,696 5,100,796
751,016 868,135
600600
2,095,462 1,297,565
3,746,530 3,761,078
12,747,304 11,028,174
238,139 238,139
12,985,443 11,266,313
15,112,129 13,406,204
8,2007,874
328,672 328,672
336,872 336,546
4,569,270 3,350,598
1,4171,417
1,110,161 922,800
645,540 735,110
1,460,132 1,460,132
7,786,521 6,470,057
8,123,393 6,806,603
407,374 407,374
523,850 523,850
968,267 968,267
5,089,245 4,700,110
6,988,736 6,599,601
6,988,736 6,599,601
15,112,129 13,406,204
Mrs. Awuneba Ajumogobia | Mrs. Bolarin Okunowo | Mr. Yomi Adenson | |
Chairman | Managing Director | Finance Director & Risk | |
FRC/2020/003/00000020872 | FRC/2020/003/00000020768 | FRC/2021/001/00000023429 |
The financial statements have been approved and authorised for issue by the board of Directors on 19th April, 2023
The accompanying notes to the financial statements form part of these financial statements.
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Chemical and Allied Products èòc published this content on 26 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2023 17:41:52 UTC.